Metal–1,10-phenanthroline-5,6-dione complexes target multidrug-resistant Acinetobacter baumannii: antibacterial and pharmacodynamic insights
Year: 2026
Type: article
Abstract: The escalating threat of antimicrobial resistance underscores the need for novel therapeutic strategies against multidrug-resistant (MDR) Gram-negative pathogens. In this context, we previously demonstrated the potent antimicrobial activity of 1,10-phenanthroline-5,6-dione (phendione) complexes with silver(I) [Ag(phendione)₂]ClO₄ (Ag-phendione) and copper(II) [Cu(phendione) 3 ](ClO 4 ) 2 ·4H 2 O (Cu-phendione) against Acinetobacter baumannii . Herein, we further characterized their antibacterial and pharmacodynamic profiles against six MDR clinical isolates of A. baumannii and the reference strain ATCC 19606. Exposure-response relationships, dose-fractionation regimens, post-antibiotic effects (PAEs), inoculum effects, carbapenem interactions, and bacterial tolerance, persistence and heteroresistance were investigated. Ag-phendione exhibited bactericidal activity against all seven strains at 16× MIC between 6 and 12 h, whereas Cu-phendione showed strain-dependent bactericidal or bacteriostatic effects. Exposure-response and dose-fractionation analyses suggested that exposure timing influenced antibacterial activity, although concentration also contributed to bacterial killing. Two doses of 0.5× MIC administered 6-h apart resulted in counts below the detection limit in 12 of 14 compound-strain conditions within 24 h. Inoculum assays showed that 3.125 µg/mL inhibited growth in 69 of 70 (98.6%) conditions. Ag-phendione produced a longer mean PAE than Cu-phendione (1.857 ± 0.378 versus 0.714 ± 0.488 h; p = 0.0156). Checkerboard assays showed predominantly additive interactions with meropenem and imipenem, whereas time-kill assays identified synergy in two of 14 meropenem–compound combinations. TDtest showed no reproducible pattern characteristic of tolerance or heteroresistance within the scope of the assay. These findings provide a foundation for further investigation of phendione-based complexes, particularly to assess their activity under physiologically relevant conditions and establish their safety and in vivo efficacy.
Source: Folia Microbiologica
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: 1,10-phenanthroline-5,6-dione, silver(I) complexes, copper(II) complexes, Acinetobacter baumannii, multidrug resistance, Gram-negative bacteria, pharmacodynamics, post-antibiotic effect, dose fractionation, meropenem, imipenem, combination therapy, heteroresistance, minimum inhibitory concentration, time-kill kinetics
Open Access status: hybrid
Estimated APC paid: $2,590
Funders: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa e Inovação do Espírito Santo, Universidade Federal do Espírito Santo
Award: G1686041357
OpenAlex ID: W7212377788
